Veru, Immunome Tout Positive Data for COVID-19 Therapeutics

Veru, Immunome Tout Positive Data for COVID-19 Therapeutics

Source: 
BioSpace
snippet: 

Veru Inc. shares were climbing rapidly in the early hours of trading Wednesday, up more than 16% after the company announced the publication of positive Phase III results from its COVID-19 antiviral therapeutic that could lead to potential Emergency Use Authorization.